View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
STUDY - GAIN-2 - Pertuzumab 840 / Trastuzumab 8, Breast Cancer, neoadjuvant, cycle 1
Protocol-ID: 767 V1.0 (Mini), STUDY-GAIN-2-PERT840/TRAS8, Breast Ca, neoadj., C1Indication(s)
- Breast Cancer (HER2+); ICD-10 C50.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 01.09.2017